City

Bethesda (1)

Condition

Advanced HNSCC (1)

Gastroesophageal Junction (GEJ) Cancers (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

National Cancer Institute (NCI) (1)

Collaborator

Intervention

n-803 (1)

pd-l1 t-hank (1)

pembrolizumab (1)

Study Documents

Intervention Type

biological (1)

drug (1)

Funder Type

NIH (1)

Study Type

Interventional (1)

advanced hnscc

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Gastroesophageal Junction (GEJ) Cancers, Advanced HNSCC Trial run by the NCI (N-803, Pembrolizumab, PD-L1 t-haNK)

Recruiting

Gastroesophageal Junction (GEJ) Cancers
Advanced HNSCC

N-803
+2 more

Bethesda, Maryland

National Institutes of Health Clinical Center

Jan 26, 2023